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Chapter 2
ASSESSING THE BIOAVAILABILITY OF ARSENIC IN
SEDIMENTS FOR USE IN HUMAN HEALTH RISK
ASSESSMENT
Pamela O. Lamie 1§
1

Camp Dresser & McKee Inc,. 50 Hampshire Street, Cambridge, MA, United States, 02139

ABSTRACT
Arsenic concentrations in sediments in a wetlands located downgradient from
a landfill in northeastern Massachusetts were found to be over 1,000 mg/kg in
several locations with a maximum detected concentration of 4,500 mg/kg. The
elevated arsenic in sediment is likely the result of the dissolution of iron and
arsenic in the underlying rock under reducing conditions mobilized with the
groundwater and co-precipitating out into the sediments when groundwater
reaches the oxidizing surface water, producing an iron and arsenic bearing floc.
Approximately 15 acres of wetlands appear to be impacted from elevated arsenic
concentrations. To assess the potential impacts to human health and to determine
the extent of acreage requiring remedial action, a site-specific bioavailability
factor was developed using an in vitro laboratory assessment. While in vivo (live
animal) studies are considered to be the most accurate measures of bioavailability
for assessing absorption of contaminants by humans, the in vivo studies are
expensive and lengthy. The in vitro approach undertaken for this assessment
simulates digestive activity in the stomach, including residence time, pH,
temperature, agitation, and solid to liquid ratio. This in vitro laboratory approach
coupled with an adjustment based on in vivo data, along with a mineralogical
characterization of the impacted sediments, served to develop a site-specific
bioavailability factor that resulted in more accurate human health risk
characterization results.
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1.

Bioavailability of Arsenic in Sediments

INTRODUCTION

Arsenic concentrations in sediments in a wetlands located downgradient from
a landfill in northeastern Massachusetts, where arsenic occurs naturally in high
concentrations in bedrock were found to be over 1,000 mg/kg in several locations
with a maximum detected concentration of 4,500 mg/kg. The elevated arsenic in
sediment is likely the result of the dissolution of arsenic and iron in the underlying
rock under reducing conditions mobilized with the groundwater and coprecipitating out into the sediments when groundwater reaches the oxidizing
surface water, producing an iron and arsenic bearing floc. Approximately 15
acres of wetlands sediments appear to be impacted from elevated arsenic
concentrations. To assess the potential impacts to human health, and to determine
the extent of acreage requiring remedial action, a site-specific arsenic
bioavailability factor was developed using an in vitro laboratory assessment
supported by other lines of evidence of reduced bioavailability.

2.

SITE HISTORY

The landfill began operating shortly after the end of World War II. Historical
mapping of the landfill area shows that the site operated as a gravel pit around this
same period of time. Dumping was conducted in an "open face" manner by filling
in old gravel pits until the early 1960s. Open burning in these pits was the primary
method of waste disposal. The landfill was used for disposal of residential,
commercial, industrial, and construction demolition wastes. Leachate from the
landfill impacted a series of streams in a wetland area adjacent to the landfill. In
1973, an underdrain system was constructed as a pollution control measure to
limit the amount of leachate entering the adjacent wetlands, and the landfill was
closed to further solid waste disposal. The landfill site continued to be used as a
recycling center and for the controlled disposal of leaves, brush and grass
cuttings. In the 1980s, soils were used to cover the northern section of the site and
ballfields were constructed.

3.

CONCEPTUAL SITE MODEL

Typically, organic matter contained within landfills produces a deoxygenated
(reducing) environment in groundwater beneath and directly downgradient of the
landfill. This removal of oxygen is caused by the degradation of the organic
matter by native microorganisms, a process that requires oxygen. Under reducing
conditions, metals such as arsenic and iron in the solid phase aquifer materials
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dissolve into the aqueous phase and become mobilized in groundwater. The
source of metals may be natural (i.e., contained within soil and rock formations or
as coatings on the surface of aquifer materials), landfilled waste, or some other
unknown source. In general, when groundwater conditions become oxidizing,
mobilized metals will typically be removed from solution as a solid precipitate.
At this site, reduced groundwater upwells into the wetland located
downgradient of the landfill (i.e., the wetland serves as a point of groundwater
discharge). When groundwater reaches the oxidizing surface water environment,
iron and arsenic in solution precipitate as solid phase iron oxyhydroxides
containing arsenic. The presence of iron and arsenic at concentrations below the
laboratory method detection limits in downgradient surface water samples appears
to indicate that the iron and arsenic are removed from solution via precipitation.
Once the iron and arsenic have been removed from solution, the resulting solid
phase particles may be transported further downstream via surface water flow. As
a result there are depositional locations with elevated concentrations of iron and
arsenic, as shown in Figure 1 below.

Figure 1. Example of iron/arsenic floc in sediment streams downgradient of the landfill.

4.

DEFINITION OF BIOAVAILABILITY

Bioavailability is the extent to which a substance can be absorbed by a living
organism and can cause an adverse physiological or toxicological response.
Bioavailability is particularly relevant for metals, which may exist in a variety of
chemical and physical forms, not all of which are readily absorbed by the body
when ingested. However, most oral reference doses (RfDs) and cancer slope
factors (CSF) used in risk assessment are based on studies in which dose is
reported as the amount of chemical ingested rather than absorbed (USEPA, 1989).
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Such studies make no assumptions concerning bioavailability. If the form of a
chemical in the environment is less than that of the form relevant to toxicology or
human epidemiological studies, these toxicity criteria may overestimate the risk.
An adjustment for reduced bioavailability of some environmental forms of
chemicals is needed in such cases to appropriately evaluate risks (USEPA, 2007).
Oral bioavailability of a substance can be expressed as either absolute
bioavailability (ABA), or as relative bioavailability (RBA). ABA is the ratio of
the amount of chemical absorbed to the amount ingested. RBA is the ratio of the
amount of a test material, such as arsenic in soil, that is absorbed to the amount of
an appropriate reference material, such as sodium arsenate. Sodium arsenate is
considered an appropriate reference material for arsenic because it is a useful
surrogate for the form(s) of arsenic on which oral toxicity criteria for arsenic are
based. Sodium arsenate is soluble and available information suggests that it is also
almost completely absorbed. Typically both ABA and RBA are expressed as a
percent. An ABA is useful for characterizing risk when a RfD and/or CSF are
based on an absorbed dose. However, since most toxicity criteria are based on an
administered dose rather than an absorbed dose, the ABA of a substance is
generally not used in the human health risk assessment process. RBA is useful
when the bioavailability of a chemical form relative to the form relevant to critical
toxicological or epidemiological studies can be estimated (USEPA, 2007).

5.

PROCESS FOR DEVELOPING A SITE-SPECIFIC ARSENIC
BIOAVAILABILITY FACTOR

5.1

In Vitro Analysis for Estimating RBA

Historically the RBA for arsenic has been determined using in vivo, (animalbased) studies. Typically the in vivo studies for arsenic have utilized young swine
or primates, and have determined RBA coefficients through the comparison of the
amount of arsenic ingested versus amount of arsenic excreted or retained in the
animal. The in vivo studies are very expensive and can take many months to
complete, but are generally accepted as the best means of assessing
bioavailability. Because of the expense and time requirements of the animal-based
studies, researchers have developed an in vitro, or laboratory-based method to
determine RBA coefficients. The efficacy of the method has been tested via
comparisons of results with those of animal studies, mainly studies where young
swine were fed arsenic containing soil.
Generally, the in vitro method consists of placing the sample medium, such as
arsenic impacted soil, into a fluid bath that simulates the human stomach. The
amount of arsenic in the bulk sample is then compared to the amount of arsenic
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that has dissolved into solution and an in vitro bioavailability (IVBA) coefficient
is calculated. The raw results from the in vitro tests are then empirically adjusted
to an in vivo RBA that is used in the risk assessment. In the in vivo studies the
amount of arsenic excreted in the urine is plotted as a function of the amount of
arsenic administered and a best fit linear regression line through the data is
determined. Using the regression slope of 0.6966, the following equation is used
to calculate the RBA (University of Colorado, 2011):
in vivo RBA = 0.6966 x in vitro RBA + 3.2482
Several studies, including one on arsenic impacted sediments from the
Aberjona River located in northeastern Massachusetts, have been conducted to
assess the correlation between in vivo and in vitro bioavailability results. These
studies suggest that the calculated IVBA is an appropriate screening tool for
estimating the relative in vivo bioavailability (Brattin and Wahlquist, 2002). For
the assessment of this site, results from 12 site samples and two reference
(background) samples submitted to the University of Colorado Laboratory for
Environmental and Geological Studies (LEGS) for in vitro analysis indicated low
RBA of arsenic in downgradient wetlands sediments, with reported values
ranging from 0.02% to 12.35% as presented in Table 1. The regression was
applied to the raw in vitro results to approximate an equivalent in vivo arsenic
RBA coefficient. The regression extrapolated in vivo RBA ranged from 3.26% to
9.94% with a 95% UCL value of 7.51%. The regression adjusted results,
however, were not accepted by MassDEP. Therefore, a maximum value of raw in
vitro value of 12.35% was selected, adjusted based on the EPA oral cancer slope
factor assuming 98% absorption (USEPA, 2011) (0.1235 / 0.98 = 0.126) and a
value of 12.6% RBA was selected for the landfill site as recommended by
MassDEP.
The correlation between the in vivo and in vitro studies for arsenic are not
strong enough to warrant using the in vitro method as a standalone means for the
determination of a site-specific arsenic bioavailability coefficient. Therefore,
additional information, such as soil mineralogy and forms of arsenic present in
this matrix, is required to demonstrate correlations between the samples analyzed
via the in vitro method and samples previously analyzed via in vivo methods.
These soil mineralogy and geochemistry characteristics are typically determined
using an electron microprobe (EMP) equipped with various spectrophotometers to
identify specific elements and mineral forms.
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Table 1. In Vitro Arsenic Bioavailability Analysis Results

Sample
1
2
3
4
5
6
7
8
9
10
11
12
referen
ce
referen
ce

5.2

Arsenic
Concentration
in Soil Sample
(µg/kg)
271,318
56,242
493,450
764,705
650,003
223,853
85,347
870,951
445,282
1,779,206
2,573,631
144,046

In Vitro
Bioavailability
Coefficient
(%)
0.02
0.10
1.53
2.09
2.58
2.60
3.51
4.34
4.57
6.81
9.61
12.35

Equivalent
In Vivo
Bioavailability
Coefficient
(%)
3.26
3.32
4.32
4.70
5.05
5.06
5.70
6.27
6.43
7.99
9.94
11.85

4,781

53.64

40.61

7,929

54.42

41.16

Geophysical Data Analysis

The three geochemical properties most commonly considered in relation to
metals bioavailability evaluated using EMP are mineral phase, matrix association,
and particle size.
•

Mineral Phase: Refers to the chemical form, or species, in which the
metal occurs in minerals composing site soil or sediment. Examples for
arsenic include iron oxides, iron and zinc sulfates, iron sulfides, and
arsenic bearing phosphates. In general, less soluble mineral phases are
associated with low RBA values. Results from the EMP work indicated
that 100% of the arsenic in all of the samples was present in a low
solubility iron oxyhydroxide phase.

•

Matrix Association: Refers to the physical association of the metal
bearing grains with other mineral phases or matrices that may limit contact
of the metal bearing grain with gastrointestinal fluids. Metal bearing
grains that are entirely free in the soil are referred to as “liberated,”
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whereas grains that are bound together are referred to as “cemented.”
Particles that exist in a secondary phase coating are referred to as
“rimming.” Metal bearing grains that are fully encased or cemented are
essentially isolated from gastrointestinal fluid, are not believed to be
available for dissolution and adsorption, and thus are typically associated
with lower RBA. The most common matrix association of the arsenic
containing particles at this site was liberated.
•

Particle Size: Metals bearing particles occur in a large variety of sizes.
Because dissolution of the particles in gastrointestinal fluid only occurs on
a particle’s surface, large particles are more likely associated with lower
RBA values than smaller ones, because the ratio of particle surface area to
volume tends to decrease as size increases. Average arsenic bearing
particle sizes, measured at the longest dimension, ranged from 27.58
microns to 61.51 microns. The average arsenic bearing particle size for all
samples was 40.8 microns.

As with any scientific research, not all lines of evidence are going to provide
the same level of support. The matrix association indicating that the arsenic
containing particles were liberated does not support the findings as strongly as the
remaining lines of evidence. While all three of the geochemical properties are
considered in the development of a site-specific RBA coefficient, mineral phase
shows the strongest correlation to bioavailability, and thus is considered more
heavily. Data collected from the Aberjona River study (Brattin and Wahlquist,
2002) suggested that the RBA of the arsenic is likely to be determined primarily
by mineral phase and/or particle size rather than by matrix association.
5.3

National Arsenic Bioavailability Library

Dr. Drexler of the University of Colorado LEGS noted that the results of the
in vitro and EMP analysis for the site sediment samples most closely resembled
soil samples collected from Keaau Hawaii as part of an arsenic bioavailability
study conducted for the State of Hawaii Department of Health. Similar to the
landfill wetland sediment samples, the Keaau samples exhibited high
concentrations of iron oxides. The soil samples collected as part of the Keaau
study were analyzed for arsenic bioavailability via the in vitro and in vivo
methods. Similar to the landfill samples, the Keaau soils exhibited low arsenic
bioavailability (AMEC, 2007). The Keaau study concluded that there was a
correlation between decreasing arsenic bioavailability with increasing iron oxide
concentrations.
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CONCLUSION

The cleanup value for arsenic in sediment at this site would be 150 mg/kg if
the default value of 100% bioavailability for arsenic was used for a child
trespasser scenario. This would result in approximately 15 acres of sediment
requiring excavation and removal. Alternatively, a site-specific cleanup value for
arsenic in sediment of 900 mg/kg was derived using a 12.6% bioavailability factor
using a child trespasser scenario. This results in five hot spot areas requiring
excavation and removal totaling approximately one half (0.5) acre of the wetlands
area. This results in a considerable reduction in the amount of wetlands that would
be disturbed/destroyed if the default value of 100% bioavailabilty was used to
assess site health risks and a substantial cost savings to the affected town.

7.
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